Recherche avancée
Affichage des résultats 2061 à 2080 sur 6512 au total
-
Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors.
Albert Fournier, Roxana Oprisiu-Fournier, Jean-Marie Serot, Olivier Godefroy, Jean-Michel Achard, Sébastien Faure, Hakim Mazouz, Mohamed Temmar, Adriana Albu, Régis Bordet, Olivier Hanon, François Gueyffier, Jiguang Wang, Sandra Black, Naoyuki Sato
-
Cognitive Therapy versus Rogerian Supportive Therapy in Borderline Personality Disorder
J. Cottraux, I. Druon Note, F. Boutitie, M. Milliery, V. Genouihlac, S.N. Yao, B. Note, E. Mollard, F. Bonasse, Sophie Gaillard, D. Djamoussian, Mey C. De, A. Culem, François Gueyffier
-
New insights on the relation between untreated and treated outcomes for a given therapy effect model is not necessarily linear
J.-P. Boissel, Michel Cucherat, P. Nonyc, Sylvie Chabaud, François Gueyffier, Jm. Wright, M. Lièvre, A. Leizorovicz
-
Meta-analysis of continuous outcomes combining individual patient data and aggregate data
Rd. Riley, Pc. Lambert, Ja. Staessen, J. Wang, François Gueyffier, L. Thijs, F. Boutitie
-
The JIKEI trial
F. Boutitie, François Gueyffier, Jm. Achard
-
Do We Need to Assess the Effect of Treatment Withdrawal? The Paradigm of Life-Long Prevention
François Gueyffier, T. Bejan-Angoulvant
-
Some reflexions about double blind
R. Boussageon, François Gueyffier, A. Moreau, Y. Gansel, V. Boussageon
-
Does a change in angiotensin-II-formation caused by antihypertensive drugs affect the risk of stroke ? A meta-analysis of trials according to treatment with potentially different effects on angiotensin-II
F. Boutitie, R. Oprisiu, J.M. Achard, H. Mazouz, J. Wang, F.H. Messerli, François Gueyffier, A. Fournier
-
Cardiovascular Risk Stratification in Decision Support Systems: A Probabilistic Approach. Application to pHealth
H. Atoui, J. Fayn, François Gueyffier, P. Rubel
-
Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock
G. Monneret, A. Lepape, N. Voirin, J. Bohé, F. Venet, A.-L. Debard, H. Thizy, J. Bienvenu, François Gueyffier, Philippe Vanhems
-
The lower the better: Does simplicity lead to absurdity?
François Gueyffier, Jm. Wright
-
Estimation of attributable burden of disease: authors' reply
François Gueyffier, Jm. Wright
-
[Readability of informed consent forms for subjects participating in biomedical research: updating is required]
Adeline Paris, Jean-Luc Cracowski, Nadia Ravanel, Catherine Cornu, François Gueyffier, Béatrice Deygas, Karine Guillot, Jean-Luc Bosson, Marc Hommel
-
Apparent effect on blood pressure is only partly responsible for the risk reduction due to antihypertensive treatments
J.-P. Boissel, François Gueyffier, F. Boutitie, S. Pocock, R. Fagard
-
Systolic and Diastolic Blood Pressure Lowering as Determinants of Cardiovascular Outcome
J.-G. Wang, J.A. Staessen, S. Franklin, R. Fagard, François Gueyffier
-
Pharmacogenetics and responders to a therapy: Theoretical background and practical problems
J.-P. Boissel, François Gueyffier, Michel Cucherat, G. Bricca
-
Prévention de la dépendance des personnes âgées : étude randomisée dans la communauté Prevention of Dependency in Elderly Persons: A Randomised Study in the Community
Catherine Cornu, C. Carré, G. Guetemme, B. Ravis, S. Thérond, François Gueyffier, M. Bonnefoy
-
Causality and statistical association (2) Mechanical determinism and stochastic model
François Gueyffier, Michel Cucherat
-
How should therapeutic information be transferred to users?
J.-P. Boissel, M. Haugh, M. Fardeheb, Patrice Nony, François Gueyffier, N. Strang
-
Le Projet INDANA : Méta-analyse sur données individuelles des essais cliniques du traitement médicamenteux de l'hypertension artérielle
François Gueyffier